Myocardial wall thickness and left ventricular geometry in hypertensives: Relationship with insulin

American Journal of Hypertension

Volumn 10, Issue 11, 1997, Pages 1250-1256

  Paolisso, Giuseppe ^a   Galderisi, Maurizio ^b   Tagliamonte, Maria Rosaria ^b   De Divitis, Marcello ^b   Galzerano, Domenico ^b   Petrocelli, Antonio ^b   Gualdiero, Pasquale ^b   De Divitis, Oreste ^b   Varricchio, Michele ^b  

^a Servizio di Astanteria Medica   (Italy)

^b NONE

Author keywords

Arterial hypertension; Echocardiographic patterns; Insulin action; Insulin resistance; Left ventricular hypertrophy; Nonoxidative glucose metabolism

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; ELECTROCARDIOGRAM; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE WALL; HUMAN; HYPERTENSION; INSULIN RELEASE; INSULIN RESISTANCE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; ECHOCARDIOGRAPHY, DOPPLER; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED;

EID: 0031279248     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00262-8     Document Type: Article

References (30)

1. 1. Levy D, Garrison RJ, Savage DD, et al: Prognostic implication of left ventricular mass in the Framingham Study. N Engl J Med 1990;332:1541-1546.
2. 2. Casale PN, Devereux RD, Milner N, et al: Value of echocardiographic measurements of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1992;117:831-836.
3. 3. Ghali JK, Liao Y, Simmons B, et al: The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992; 117:831-836.
4. 4. Desprès JP, Lamarche B, Mauriege P, et al: Hyperinsulinemia as an independent risk factor for ischemic heart diseases. N Engl J Med 1996;334:952-957.
5. 5. Sasson Z, Rossoly Y, Bhesonie T, Rossoly T.: Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation 1993;88:1431-1436.
6. 6. Sharp SD, Williams RR: Fasting insulin and left ventricular mass in hypertensive and normotensive controls. General Cardiol 1992;81:207-221.
7. 7. Paolisso G, Galzerano D, Gambardella A, et al: Left ventricular hypertrophy is associated with a stronger impairment of non-oxidative glucose metabolism in hypertensive patients. Eur J Clin Invest 1995;25:529-533.
8. 8. Reaven GM, Lithell H, Landsberg L: Hypertension and associated metabolic abnormalities: the role on insulin resistance and the sympathoadrenal system. N Engl J Med 1996;334 (6):374-381.
9. 9. Koren MJ, Devereux RB, Casale PN, et al: Relation of left ventricular mass and geometry to morbidity and mortality in men and women with essential hypertension. Ann Intern Med 1991;114:345-352.
10. 10. Aronow WS, Ahn C, Kronzon I, Koenigsberg M: Congestive heart failure, coronary events, and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without echocardiographic and electrocardiographic evidences of left ventricular hypertrophy. Am J Cardiol 1991;67:295-299.
11. 11. Devereux RB: Left ventricular geometry, pathophysiology and prognosis. J Am Coll Cardiol 1995;25:885-887.
12. 12. Krumholz HM, Larson M, Levy D: Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 1995;25:879-884.
13. 13. Sahn DJ, De Maria A, Kisslo J, Weiman A, for the Committee on M-mode Standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
14. 14. Devereux RB, Reicheck N: Echocardiographic determination of left ventricular mass in men. Circulation 1997;55:613-618.
15. 15. Levy D, Savage DD, Garrrison RJ, et al: Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987;59:956-960.
16. 16. Galderisi M, Lauer MS, Levy D: Echocardiographic determinants of clinical outcome in subjects with coronary artery disease (The Framingham Heart Study). Am J Cardiol 1992;70:971-976.
17. 17. Sanau A, Devereux RB, Roman MJ, et al: Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19:1550-1558.
18. 18. Diabetes Mellitus: A report of a WHO study group. World Health Organization 1985;727:9-17.
19. 19. De Fronzo RA, Tobin JD, Anderson R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-223.
20. 20. Bonadonna RC, Saccomani MP, Seely L, et al: Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes 1993;42:191-198.
21. 21. De Fronzo RA, Ferrannini E, Hendler R, et al: Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 1983;32: 35-41.
22. 22. Paolisso G, Gambardella A, Balbi V, et al: Effects of magnesium and nifedipine on insulin action, substrate oxidation and blood pressure in aged hypertensive patients. Am J Hypertens 1993;6:920-926.
23. 23. Ferrannini E: The theoretical basis of indirect calorimetry: a review. Metabolism 1988;37:287-301.
24. 24. Barbagallo M, Gupta RK, Resnick LM: Cellular ions in NIDDM: relation of calcium to hyperglycemia and cardiac mass. Diabetes Care 1996;19:1393-1398.
25. 25. De Fronzo RA: The effect of insulin on renal sodium metabolism. Diabetologia 1981;21:165-171.
26. 26. De Fronzo RA, Ferrannini E: Insulin resistance. A multifaced syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and cardiovascular disease. Diabetes Care 1991;14:173-194.
27. 27. Strauss DG: Growth-stimulatory action of insulin in vitro and in vivo. Endocrine Rev. 1984;5:356-367.
28. 28. Hill DJ, Milner DG: Insulin as growth factor. Pediatr Res 1985;19:879-886.
29. 29. Banskata NK, Taub R, Zellner K, et al: Characterization of induction of proto-oncogene c-myc and cellular growth in human vascular smooth cells by insulin and IGF-I. Diabetes 1989;38:123-129.
30. 30. Nakamura NH, Kohara K, Sumimoto T, et al: Glucose intolerance exaggerates left ventricular hypertrophy and dysfunction in essential hypertension. Am J Hypertens 1994;7:1110-1114.